Fig. 1: Correlation between asymmetric dimethylarginine (ADMA) and other parameters among each group.

a Correlation between ADMA and low denisty lipoprotein (LDL) in valproate-treated patients. b Correlation between ADMA and triglycerides in valproate-treated patients. c Correlation between ADMA and low denisty lipoprotein (LDL) in multidrug-treated patients. d Correlation between ADMA and homocysteine in multidrug-treated patients.